Edition: United Kingdom  
One News Page
“Probably the fastest-access news portal in the world”
> >

Merck to halt study of mild to moderate Alzheimer's drug

Reuters Tuesday, 14 February 2017 ()
(Reuters) - Merck & Co Inc said it would halt a late-stage trial of its drug in patients with mild to moderate Alzheimer's disease after an external panel pointed to a lack of effectiveness.
0
shares
Share on
Facebook
Share on
Twitter
Post on 
Reddit
Share by
Email
 
Source: Wochit News - < > Embed

News video: Scientists Disappointed After New Alzheimer's Drug Failed

Scientists Disappointed After New Alzheimer's Drug Failed 00:35

Researchers found that the new promising Alzheimer’s drug verubecestat did not work. Dr. Roger Perlmutter, president of Merck Research Laboratories, stated, “While we are disappointed that a benefit was not observed in this study, our work continues [to study the impact of] verubecestat in people...

You Might Like


Other recent news in Health

ONLINE DATING, speed dating, casual dating + other types of modern dating decoded!SpaceX Announces Plans To Sent Two Customers To THE MOON
Review into Hugh Papik's death calls for cultural training for HEALTH CARE workersRepublicans will fail in Obamacare repeal bid: top SENATE Democrat
The mental health cost of unchecked CLIMATE CHANGEVaccine Safety Commission: 50 studies the AAP failed to send PRESIDENT TRUMP
MARRIED people are healthier, study finds

Twitter

Environmentally friendly: One News Page is hosted on servers powered solely by renewable energy
© 2017 One News Page Ltd. All Rights Reserved.  |  About us  |  Disclaimer  |  Press Room  |  Terms & Conditions  |  Privacy Policy  |  Content Accreditation
 RSS  |  News for my Website  |  Free news search widget  |  Help  |  Contact us  |  DMCA / Content Removal
How are we doing? Send us your feedback  |   LIKE us on Facebook   FOLLOW us on Twitter   FIND us on Google+